19-Year-Old’s Breasts Quadruple in Size After Pfizer COVID Vaccine Autoimmune Reaction

A 19-year-old woman from Canada developed a rare and dramatic medical condition following the Pfizer Covid vaccine, with her breast size increasing from a B cup to a triple G within six months.

The case, believed to be linked to an autoimmune response triggered by the vaccine, has raised concerns about potential rare side effects of mRNA technology and the need for further investigation.

Many women reported their breasts and lymph nodes had “swollen” after receiving their jabs, dubbing the effect the “Pfizer boob job”, however Big Pharma and government agencies told them they were wrong.

However, cases of gigantomastia are now receiving increased attention from medical researchers, who have identified it as yet another potential side effect of the Covid vaccines.

The young Canadian woman received her first dose of the Pfizer Covid vaccine in September 2022. Initially, she noticed mild tingling and a slight increase in breast size. But following her second dose just three weeks later, the changes became undeniable.

Over the next six months, her breasts continued to swell dramatically, forcing her to seek medical attention.

By the time she consulted doctors, her breast size had quadrupled, reaching proportions far beyond the average North American woman’s DD cup. The physical and emotional toll was immense, as her condition affected her health, daily life and self-esteem.

Doctors diagnosed the woman with pseudoangiomatous stromal hyperplasia (PASH), a rare, benign overgrowth of breast tissue following an immune response. While PASH has only been documented in about 200 cases globally, cases are believed to be rising in response to the mRNA vaccine roll out in 2021.

Although medical experts were cautious about labeling the Pfizer vaccine as the definitive cause, they couldn’t ignore the timing. Multiple studies have shown that Covid vaccines trigger immune responses, including swollen lymph nodes, which can lead to temporary breast enlargement.

The experts, from the University of Toronto, wrote in a medical journal last month: “This case is the first to demonstrate a temporal association between PASH-associated gigantomastia and a vaccine.”

Eleven months after her first vaccine dose, the woman underwent a grueling breast reduction surgery, during which surgeons removed a staggering 8 pounds of tissue.

While the procedure reduced her size to a double D cup, it left her with asymmetrical breasts, prompting discussions of additional corrective surgeries.

The physical ordeal was matched by emotional struggles, as she grappled with a sudden and dramatic change to her body that disrupted her sense of identity.

This shocking case reignites debates about the long-term safety of mRNA vaccines. While billions of doses have been administered worldwide with overwhelmingly positive outcomes, bizarre incidents like this underscore the need for ongoing research into rare side effects.